Author

M. C. Föll

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Research Focus:software / tool· 1

Frequent Co-Authors

O. Schilling· 2 shared B. A. Grüning· 1 shared B. Warscheid· 1 shared D. Glätzer· 1 shared D. Guo· 1 shared F. Drepper· 1 shared J. Johnson· 1 shared K. Enderle-Ammour· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

O. Schilling

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MaxQuant and MSstats in Galaxy enable reproducible cloud-based analysis of quantitative proteomics experiments for everyone

N. Pinter, D. Glätzer, M. Fahrner, K. Fröhlich, J. Johnson, B. A. Grüning, B. Warscheid, F. Drepper, O. Schilling, M. C. Föll

The paper integrates MaxQuant and MSstats into Galaxy for reproducible cloud-based quantitative proteomics analysis, enabling accessible and transparent workflows for researchers.

bioRxiv · Jan 20, 2022Biochemistry

Moving translational mass spectrometry imaging towards transparent and reproducible data analyses: A case study of an urothelial cancer cohort analyzed in the Galaxy framework

M. C. Föll, V. Volkmann, K. Enderle-Ammour, K. Wilhelm, D. Guo, O. Vitek, P. G. C. Bronsert, O. Schilling

The paper demonstrates reproducible mass spectrometry imaging analysis of urothelial cancer tissue using the Galaxy framework, achieving high classification accuracy for tumor vs. stroma and muscle-invasive status.

bioRxiv · Aug 9, 2021Cancer Biology